0001628280-24-000639.txt : 20240105 0001628280-24-000639.hdr.sgml : 20240105 20240105155200 ACCESSION NUMBER: 0001628280-24-000639 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231017 FILED AS OF DATE: 20240105 DATE AS OF CHANGE: 20240105 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ACKERMAN JOEL CENTRAL INDEX KEY: 0001220630 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-11504 FILM NUMBER: 24516080 MAIL ADDRESS: STREET 1: COVENTRY HEALTH CARE, INC. STREET 2: 6705 ROCKLEDGE DR SUITE 900 CITY: BETHESDA STATE: MD ZIP: 20817 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CHAMPIONS ONCOLOGY, INC. CENTRAL INDEX KEY: 0000771856 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 521401755 STATE OF INCORPORATION: DE FISCAL YEAR END: 0430 BUSINESS ADDRESS: STREET 1: 855 N. WOLFE STREET STREET 2: SUITE 619 CITY: BALTIMORE STATE: MD ZIP: 21205 BUSINESS PHONE: 410-369-0365 MAIL ADDRESS: STREET 1: 855 N. WOLFE STREET STREET 2: SUITE 619 CITY: BALTIMORE STATE: MD ZIP: 21205 FORMER COMPANY: FORMER CONFORMED NAME: CHAMPIONS BIOTECHNOLOGY, INC. DATE OF NAME CHANGE: 20070220 FORMER COMPANY: FORMER CONFORMED NAME: CHAMPIONS SPORTS INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: INTERNATIONAL GROUP INC DATE OF NAME CHANGE: 19860319 4 1 wk-form4_1704487909.xml FORM 4 X0508 4 2023-10-17 0 0000771856 CHAMPIONS ONCOLOGY, INC. CSBR 0001220630 ACKERMAN JOEL C/O CHAMPIONS ONCOLOGY, INC. ONE UNIVERSITY PLACE, SUITE 307 HACKENSACK NJ 07601 1 0 0 0 0 Common Stock 2023-10-17 4 M 0 114552 2.10 A 856997 D Option to purchase Common Stock 2.10 2023-10-17 4 M 0 100000 2.10 D 2016-07-19 2023-11-05 Common Stock 100000 0 D Option to purchase Common Stock 2.10 2023-10-17 4 M 0 14552 2.10 D 2016-07-19 2023-11-05 Common Stock 14552 0 D 84,600 options were immediately exercisable upon grant on July 19, 2016 with the remaining options vesting on August 5, 2016 and November 5, 2016. The options were immediately exercisable upon grant on July 19, 2016. /s/ Joel Ackerman 2024-01-05